A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer.

Abstract

The detection of somatic epidermal growth factor receptor (EGFR) mutations is valuable when an appropriate therapy, either EGFR-tyrosine kinase inhibitor (TKI) therapy or chemotherapy, for patients with advanced non-small cell lung cancer (NSCLC) needs to be selected. Although it is well‑understood that EGFR mutation detection is significant for the… (More)
DOI: 10.3892/ijmm.2014.1789

Topics

Cite this paper

@article{Yi2014ACO, title={A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer.}, author={Suqin Yi and Yuan Zhuang and Jun Zhou and Haitao Ma and Jianan Huang and Lin Wang and Weidong Zhu and Suya Kang and Linchuan Guo and Feng Guo}, journal={International journal of molecular medicine}, year={2014}, volume={34 2}, pages={464-74} }